Cargando…
Adding ultralow-dose oral naltrexone to morphine: a double-blind, randomized clinical trial
Autores principales: | Farahmand, S, Ahmadi, O |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2934121/ http://dx.doi.org/10.1186/cc8714 |
Ejemplares similares
-
Low-dose naltrexone for the treatment of fibromyalgia: protocol for a double-blind, randomized, placebo-controlled trial
por: Bruun, Karin Due, et al.
Publicado: (2021) -
High-dose versus low-dose nebulized albuterol in acute asthmatic attack: a randomized double-blind clinical trial
por: Hosseinnezhad, A, et al.
Publicado: (2005) -
Ultralow Dose of Naloxone as an Adjuvant to Intrathecal Morphine Infusion Improves Perceived Quality of Sleep but Fails to Alter Persistent Pain: A Randomized, Double-blind, Controlled Study
por: Block, Linda, et al.
Publicado: (2015) -
The Effect of Adding Low-Dose Naloxone to Intrathecal Morphine on Postoperative Pain and Morphine Related Side Effects after Cesarean Section: A Double-Blind, Randomized, Clinical Trial
por: Peivandi, Saloumeh, et al.
Publicado: (2019) -
Ultra-low dose naltrexone attenuates chronic morphine-induced gliosis in rats
por: Mattioli, Theresa-Alexandra M, et al.
Publicado: (2010)